Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
IMM could consider to do a share consolidation to boost the share price. I wouldn't say 400m shares IMM have now in circulation is too high. To bring it down under 100m would be nice. Certainly would boost the share price for sure.
Quite amazing IMM still have only 400m shares considering the number of years they been operating since their formation and never had share consolidation done. Don't be fooled by other pharma peers on AIM having only tens of millions shares in circulation. Almost all of them have had share consolidation done otherwise they would be in multi billions, if not high in hundred of millions.
And we can expect updates on our assets.
The sp is on its knees as the moment, very undervalued imo.
Gla
Thanks Flash
I can wait - buy on rumour!
If one IS Reading between the Lines , a commercial deal seems imminent.
As Saïd before
-The u turns With the protocols suggest a third party implication
- Tim not doing any share raides
And now the stock options
All these things could imply that a deal is near , but as Always , everyone to their own convictions and trades !
Obviously they need to achieve certain key things before any kind of £10m up front payment would land on their laps ,but Tim does seem to think something will come within 2024 ..
" ....with the objective of completing deals across the portfolio in 2024."
The 3 year clause also keeps the team together with the incentive to stay with the company long enough to hopefully exercise the Options ...you have to value the team or if not they will go elsewhere
Pretty sure we could see 20-30m being brought in and at current levels this looks like we could see 8-12p, but trial success will yield the biggest gains
If you listen to the latest video and rns's the window fkr commercial deals is nlw open. Why long it out!
Last day of the conference today.
Gla
Thanks for your interpretation..
So , for you , significant = £10 million upfront ?
That IS significant when one compares it With the present Mcap
For what it is worth the company are hoping for significantly larger deals than I have suggested but having been bruised and battered over 8 years I prefer to quote much more conservative numbers
Nolupus
I think a deal on the Rest of World rights on Lupuzor of possibly £10m upfront plus and royalties etc given that Alora has invested $25m to fund the Phase 3 plus chucked in c£1m at 11p for the US Lupus rights representing 60% of the world wide Lupus market.
I think a deal on CIDP for global rights could be done at c£10m /15 m plus royalties.
Immupharma is trying to become a royalties income company with a R&D operation in France.
So two upfront payment deals on the late stage drugs could yield c£20/25m in commercial deals which is peanuts in the Global pharma industry imho.
Nolupus you that many a slip between cup and lip.
Dallo,
What do you think this means ?
When the Company has completed a new commercial deal of significant value
The main reason for the structure of the options is to give the holders TIME ie 3 years to get the share price up to a level where they could finance the exercise of the 25m costing £500,000 which I don't think they would have the resources to do if say the SP just moved to even 10p in an AIM share.
However if the SP is 20/25p or even higher in 3 years time then no problem in financing as they would sell enough shares on exercise to repay any lender.
I don't begrudge the options to management as the stakes are so high and the salaries alone are not a sufficient incentive for them to work their butts off to make a success of Immupharma.
This is McCarthy's last rodeo and if Immupharma and Incanthera are a success he is set for a nice retirement
I wish him and the team well as we all benefit from a successful Immupharma.
Wonderful debate today on the options clauses which in a headmaster way , I will try to clarify.
The LATTER in used in the context of the mention of things, people, situations, options ,choices et al as the 2nd of the TWO mentioned with the FORMER the 1st
Accordingly if a commercial deal is done before the 3 years , the 3 years time frame becomes the LATTER and the commercial deal becomes the FORMER.
Conversely if the 3 years passes by and a commercial deal is done afterwards then the commercial deal becomes the LATTER and the 3 years is the FORMER.
God forbid there was a typo and the LATTER should have read "LATER".
I need a drink
I think we've done today's RNS to death now.
there is a fundamental difference between the words "and" & "or2.
Anyone who doesn't get that by now really shouldn't be investing in anything.
Flash212,
Did you went to your mummy and daddy Pokerchips, Dallo and Nolupus to argue for you?
Its obvious The word "latter" is confusing lots of us here. I must admit the wording of the RNS is ambiguous. The way I see it is, the two conditions the significant deal and the 3 years from date of issue are connected. They are conjoined together and cannot be separated. The grant of share options can only be vested after 3 years which is the latter, but only if the significant deal is done with it.
Nope I'm one of the kind 😌
Goldgirl ,
Are you the lady With the café in Malta ?
You sound very like her, but i must be confused in my old age :-)
I really believe Tim can do this.
We have 3 main assets and he talk about getting in at bottom and riding the share up. He is beaming with confidence in his last interview video.
Gla
Wigwammer,
Well said.
Well I very rarely post on this board, nolupus. But I do think the purpose of these boards is for fun as well as to gather information. I understand why people come here and talk enthusiastically about their investments - that seems human. Buyer beware and only bet what you can afford, of course… But I have no idea why people come here and repeatedly and blandly undermine every announcement and every positive suggestion. That behaviour is just weird. Hope that explains. ATB
Wigwammer,
Without defending the persons you mention and would like to ridiculise ...
How Come you don't ever talk like that to the ' Strong buy' ' crowd who have been more of a liability and so very very wrong over the years ?
Should they not get the same sentence ?
Flash:
I don't know if you can't read, but the RNS does NOT say, a significant deal OR a minimum of 3 years, it says AND which does not mean the same as OR.
Can't you also read the other contributors to this site who explain the full meaning of the conditions attached to the share options.
Are you a fool or a knave?
Flash:
I don't know if you can't read, but the RNS does NOT say, a significant deal OR a minimum of 3 years, it says AND which does not mean the same as OR.
Can't you also read the other contributors to this site who explain the full meaning of the conditions attached to the share options.
Are you a fool or a knave?
These options are reasonable compensation given that management are likely not currently paying themselves much. And that is why they are able to commit to no near term dilution. Like him or not, TM has kept IMM afloat and done a good job developing a relationship with Avion which gives them a reasonable chance of building something from here. He deserves to be remunerated for that, these sizeable option will hopefully keep him interested in the possible absence of a salary. ATB
Flash212/Lambo - I really hope no one acted on your daft posts and sold near the lows. What a liability…